Coya Therapeutics, Inc.
Recent Filings
All 210 filings →| Form | Description | Date |
|---|---|---|
| EFFECT | — | Mar 20, 2026 |
| 424B3 | 424B3 | Mar 20, 2026 |
| S-3 | S-3 | Mar 16, 2026 |
| 10-K | 10-K | Mar 16, 2026 |
| 8-K | 8-K | Mar 16, 2026 |
| SCHEDULE 13G | — | Mar 12, 2026 |
| SCHEDULE 13G/A | — | Jan 30, 2026 |
| 8-K | 8-K | Jan 30, 2026 |
| SCHEDULE 13G/A | — | Jan 28, 2026 |
| 4 | 4 | Jan 26, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| SNYDER DAVID S | Chief Financial Officer | Purchase | 1,800 @ $7.19 | 8,800 | Nov 14, 2024 |
| Swaminathan Arun | Chief Executive Officer | Purchase | 5,000 @ $7.36 | 10,000 | Nov 13, 2024 |
| Grossman Fred | Chief Medical Officer | Purchase | 2,710 @ $7.37 | 2,710 | Nov 11, 2024 |
| Swaminathan Arun | Chief Executive Officer | Purchase | 5,000 @ $7.34 | 5,000 | Nov 11, 2024 |
| Lee Ann | — | Purchase | 1,000 @ $3.62 | 17,479 | Aug 22, 2023 |
| Berman Howard | Chief Executive Officer | Purchase | 10,000 | 10,000 | Jan 3, 2023 |
| Hepner Adrian | Chief Medical Officer | Purchase | 10,000 | 10,000 | Jan 3, 2023 |
| Garren Hideki | — | Purchase | 2,000 | 2,000 | Jan 3, 2023 |
| SNYDER DAVID S | Chief Financial Officer | Purchase | 7,000 | 7,000 | Jan 3, 2023 |
| Villalobos Anabella | — | Purchase | 10,000 | 10,000 | Jan 3, 2023 |